MedVellum
MedVellum
Back to Library
Haematology
Oncology
EMERGENCY

Acute Leukaemia

High EvidenceUpdated: 2025-12-25

On This Page

Red Flags

  • Signs of severe infection (fever, sepsis)
  • Signs of severe bleeding
  • Signs of severe anemia
  • Signs of hyperleukocytosis (respiratory distress, neurological symptoms)
  • Signs of tumor lysis syndrome
Overview

Acute Leukaemia

1. Clinical Overview

Summary

Acute leukaemia is a cancer of the blood and bone marrow where immature blood cells (blasts) multiply rapidly and crowd out normal blood cells. Think of your bone marrow as a factory that makes blood cells—in acute leukaemia, the factory starts making too many immature, non-functional cells (blasts) that can't do their job, while normal blood cells (red cells, white cells, platelets) can't be made properly. This leads to three main problems: anemia (not enough red cells—fatigue, breathlessness), infection (not enough normal white cells—fever, infections), and bleeding (not enough platelets—bruising, bleeding). There are two main types: acute myeloid leukaemia (AML—affects myeloid cells) and acute lymphoblastic leukaemia (ALL—affects lymphoid cells, more common in children). Acute leukaemia is a medical emergency that requires urgent treatment. The key to management is recognizing the condition (symptoms of anemia, infection, bleeding, sometimes organ infiltration), confirming the diagnosis (blood tests showing blasts, bone marrow biopsy), classifying the type and subtype (essential for treatment), and urgent chemotherapy (induction chemotherapy to achieve remission, then consolidation/maintenance). Early recognition and prompt treatment are essential—delayed treatment significantly increases mortality.

Key Facts

  • Definition: Cancer of blood and bone marrow with rapid multiplication of immature blood cells
  • Incidence: Rare (3-5 per 100,000 per year)
  • Mortality: High (30-50% overall, varies by type and age)
  • Peak age: Bimodal (children for ALL, older adults for AML)
  • Critical feature: Anemia, infection, bleeding, blasts in blood/bone marrow
  • Key investigation: Blood tests (FBC showing blasts), bone marrow biopsy
  • First-line treatment: Urgent chemotherapy (induction)

Clinical Pearls

"Think of it with pancytopenia" — If a patient has pancytopenia (low red cells, white cells, platelets) with blasts in the blood, think acute leukaemia. Don't miss this.

"Fever + pancytopenia = infection until proven otherwise, but also think leukaemia" — Fever with low blood counts can be infection (neutropenic sepsis), but can also be the presenting feature of leukaemia. Check for blasts.

"Bone marrow biopsy is essential" — Blood tests may show blasts, but bone marrow biopsy is essential to confirm, classify the type, and guide treatment. Don't skip this.

"Time matters" — Acute leukaemia is a medical emergency. Once diagnosed, treatment should start urgently (usually within days). Delayed treatment increases mortality.

Why This Matters Clinically

Acute leukaemia is a life-threatening condition that requires urgent recognition and treatment. Early recognition (especially pancytopenia with blasts), prompt diagnosis (bone marrow biopsy), and urgent chemotherapy are essential. This is a condition that haematologists and oncologists manage, and prompt treatment can be life-saving.


2. Epidemiology

Incidence & Prevalence

  • Overall: Rare (3-5 per 100,000 per year)
  • AML: More common in adults (2-3 per 100,000)
  • ALL: More common in children (1-2 per 100,000)
  • Trend: Stable (rare condition)
  • Peak age: Bimodal (children for ALL, older adults for AML)

Demographics

FactorDetails
AgeBimodal (children 2-5 years for ALL, older adults 60+ years for AML)
SexSlight male predominance
EthnicitySlight variation (some populations)
GeographyNo significant variation
SettingHaematology, oncology units

Risk Factors

Non-Modifiable:

  • Age (older = higher risk for AML)
  • Previous chemotherapy (higher risk)
  • Genetic syndromes (higher risk)

Modifiable:

Risk FactorRelative RiskMechanism
Previous chemotherapy5-10xTreatment-related leukaemia
Radiation exposure3-5xTreatment-related leukaemia
Smoking2-3xAML
Benzene exposure3-5xAML

Common Types

TypeFrequencyTypical Patient
AML50-60%Older adults
ALL30-40%Children, young adults
Other5-10%Various

3. Pathophysiology

The Leukaemia Mechanism

Step 1: Genetic Mutation

  • Mutation: Genetic mutation in blood cell precursor
  • Result: Cell becomes cancerous

Step 2: Uncontrolled Growth

  • Multiplication: Cancerous cells multiply rapidly
  • Crowding: Crowd out normal cells in bone marrow
  • Result: Normal cells can't be made

Step 3: Pancytopenia

  • Anemia: Not enough red cells
  • Neutropenia: Not enough normal white cells
  • Thrombocytopenia: Not enough platelets
  • Result: Pancytopenia

Step 4: Clinical Manifestation

  • Anemia symptoms: Fatigue, breathlessness
  • Infection: Fever, infections
  • Bleeding: Bruising, bleeding
  • Result: Clinical presentation

Step 5: Organ Infiltration (Sometimes)

  • Blasts invade: Blasts can invade organs
  • Organ dysfunction: Organs don't work properly
  • Result: Organ-specific symptoms

Classification by Type

TypeDefinitionClinical Features
AMLMyeloid cells affectedMore common in adults
ALLLymphoid cells affectedMore common in children

Anatomical Considerations

Bone Marrow:

  • Factory: Makes all blood cells
  • Crowded: Leukaemia cells crowd out normal cells
  • Result: Can't make normal cells

Organ Infiltration:

  • Can invade: Any organ
  • Common: Liver, spleen, lymph nodes, CNS (ALL)
  • Result: Organ dysfunction

4. Clinical Presentation

Symptoms: The Patient's Story

Typical Presentation:

History:

Signs: What You See

Vital Signs (May Be Abnormal):

SignFindingSignificance
TemperatureMay be elevated (fever, infection)Fever, infection
Heart rateMay be high (anemia, fever)Tachycardia
Blood pressureUsually normal (may be low if sepsis)Usually normal
Respiratory rateMay be high (anemia, infection)Tachypnea

General Appearance:

Examination Findings:

FindingWhat It MeansFrequency
PallorAnemiaCommon
BruisingThrombocytopeniaCommon
PetechiaeThrombocytopeniaCommon
HepatosplenomegalyOrgan infiltration30-40%
LymphadenopathyOrgan infiltration20-30%
Gum hypertrophyOrgan infiltration (AML)10-20% (AML)

Signs of Complications:

Red Flags

[!CAUTION] Red Flags — Immediate Escalation Required:

  • Signs of severe infection (fever, sepsis) — Medical emergency, needs urgent antibiotics
  • Signs of severe bleeding — Medical emergency, needs urgent platelets, support
  • Signs of severe anemia — Needs urgent blood transfusion
  • Signs of hyperleukocytosis (respiratory distress, neurological symptoms) — Medical emergency, needs urgent treatment
  • Signs of tumor lysis syndrome — Medical emergency, needs urgent treatment

Fatigue
Severe fatigue (anemia)
Fever
Fever, infections (neutropenia)
Bleeding
Bruising, bleeding (thrombocytopenia)
Other
Varies by organ infiltration
5. Clinical Examination

Structured Approach: ABCDE

A - Airway

  • Assessment: Usually patent
  • Action: Secure if compromised

B - Breathing

  • Look: May have respiratory distress (anemia, infection, hyperleukocytosis)
  • Listen: May have crackles (infection)
  • Measure: SpO2 (may be low)
  • Action: Support if needed

C - Circulation

  • Look: Signs of anemia, bleeding
  • Feel: Pulse (may be fast), BP (usually normal)
  • Listen: Heart sounds (may have flow murmur if anemia)
  • Measure: BP (usually normal), HR (may be fast)
  • Action: Monitor if severe

D - Disability

  • Assessment: May have neurological symptoms (if CNS involvement or hyperleukocytosis)
  • Action: Assess if severe

E - Exposure

  • Look: Full examination, look for bruising, organ enlargement
  • Feel: Liver, spleen, lymph nodes
  • Action: Complete examination

Specific Examination Findings

Hematological Examination:

  • Pallor: Anemia
  • Bruising: Thrombocytopenia
  • Petechiae: Thrombocytopenia
  • Active bleeding: If severe

Organ Examination:

  • Hepatosplenomegaly: Organ infiltration
  • Lymphadenopathy: Organ infiltration
  • Gum hypertrophy: Organ infiltration (AML)
  • CNS: May have signs if CNS involved (ALL)

Special Tests

TestTechniquePositive FindingClinical Use
FBCBlood testPancytopenia, blastsDiagnostic
Bone marrow biopsyBone marrow sampleBlasts, confirms diagnosisEssential

6. Investigations

First-Line (Bedside) - Do Immediately

1. Blood Tests (Essential)

  • FBC: Shows pancytopenia, blasts
  • Action: High suspicion if blasts present

2. Bone Marrow Biopsy (Essential)

  • Purpose: Confirms diagnosis, classifies type
  • Action: Essential for diagnosis and treatment planning

Laboratory Tests

TestExpected FindingPurpose
Full Blood CountPancytopenia, blastsDiagnostic
Bone marrow biopsyBlasts, confirms typeEssential for diagnosis
CytogeneticsGenetic abnormalitiesPrognosis, treatment
ImmunophenotypingCell markersClassifies type
CoagulationMay be abnormalAssesses bleeding risk

Imaging

Chest X-Ray (If Respiratory Symptoms):

IndicationFindingClinical Note
Respiratory symptomsMay show infection, mediastinal massIf symptoms

CT (If Organ Involvement):

IndicationFindingClinical Note
Organ involvementOrgan enlargement, infiltrationIf suspected

Diagnostic Criteria

Clinical Diagnosis:

  • Pancytopenia + blasts in blood + bone marrow showing leukaemia = Acute leukaemia

Type Classification:

  • AML: Myeloid blasts
  • ALL: Lymphoid blasts

Severity Assessment:

  • Standard risk: Better prognosis
  • High risk: Worse prognosis (based on genetics, age, etc.)

7. Management

Management Algorithm

        SUSPECTED ACUTE LEUKAEMIA
    (Pancytopenia + blasts + symptoms)
                    ↓
┌─────────────────────────────────────────────────┐
│         IMMEDIATE ASSESSMENT                     │
│  • Blood tests (FBC showing blasts)                │
│  • Assess for complications (infection, bleeding) │
│  • High suspicion                                 │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         BONE MARROW BIOPSY (ESSENTIAL)           │
│  • Confirms diagnosis                              │
│  • Classifies type (AML vs ALL)                    │
│  • Cytogenetics, immunophenotyping                 │
│  • Essential for treatment planning                │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         TREAT COMPLICATIONS (URGENT)              │
│  • Infection: Antibiotics (if fever, neutropenia) │
│  • Bleeding: Platelets (if bleeding)               │
│  • Anemia: Blood transfusion (if severe)          │
│  • Hyperleukocytosis: Urgent treatment            │
│  • Tumor lysis: Prevention, treatment              │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         URGENT CHEMOTHERAPY                      │
├─────────────────────────────────────────────────┤
│  AML                                             │
│  → Induction chemotherapy (usually 7+3)           │
│  → Consolidation chemotherapy                    │
│  → May need stem cell transplant                  │
│                                                  │
│  ALL                                             │
│  → Induction chemotherapy                        │
│  → Consolidation, maintenance                     │
│  → CNS prophylaxis (ALL)                         │
│  → May need stem cell transplant                  │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         SUPPORTIVE CARE                           │
│  • Infection prevention, treatment                 │
│  • Blood product support                           │
│  • Monitor for complications                       │
└─────────────────────────────────────────────────┘
                    ↓
┌─────────────────────────────────────────────────┐
│         MONITOR & FOLLOW-UP                       │
│  • Monitor response to treatment                   │
│  • Assess for remission                           │
│  • Long-term management                            │
└─────────────────────────────────────────────────┘

Acute/Emergency Management - The First Hour

Immediate Actions (Do Simultaneously):

  1. Blood Tests (Urgent)

    • FBC: Check for blasts, pancytopenia
    • Action: High suspicion if blasts present
  2. Assess for Complications (Urgent)

    • Infection: If fever, neutropenia—urgent antibiotics
    • Bleeding: If bleeding—urgent platelets
    • Anemia: If severe—blood transfusion
    • Action: Treat complications urgently
  3. Bone Marrow Biopsy (Urgent)

    • Purpose: Confirm diagnosis, classify type
    • Action: Essential, don't delay
  4. Haematology Consultation (Urgent)

    • Urgent: Usually within 24 hours
    • Action: Don't delay
  5. Prepare for Chemotherapy

    • Assess fitness: Assess if fit for chemotherapy
    • Action: Plan treatment

Medical Management

Supportive Care (Essential):

InterventionDetailsNotes
AntibioticsIf fever, neutropeniaUrgent, broad-spectrum
PlateletsIf bleeding or very lowPrevent/treat bleeding
Blood transfusionIf severe anemiaSupport circulation
Tumor lysis preventionAllopurinol, hydrationPrevent TLS

Chemotherapy (Essential):

TypeRegimenNotes
AML inductionUsually 7+3 (cytarabine + anthracycline)Induction
ALL inductionMulti-drug regimenInduction
ConsolidationAs appropriateAfter remission

Disposition

Admit to Hospital:

  • All cases: Need chemotherapy, monitoring
  • ICU: If complications (sepsis, etc.)

Discharge Criteria:

  • Not applicable initially: All need admission
  • When stable: Can discharge between cycles

Follow-Up:

  • Regular: Monitor response, complications
  • Long-term: Ongoing management
  • Remission: Monitor for relapse

8. Complications

Immediate (Days-Weeks)

ComplicationIncidencePresentationManagement
Infection50-70%Fever, sepsisAntibiotics, supportive care
Bleeding30-40%Bleeding, hemorrhagePlatelets, supportive care
Tumor lysis syndrome10-20%Renal failure, electrolyte imbalancesPrevention, treatment
Death20-30% (if not treated)If not treatedPrevention through early treatment

Infection:

  • Mechanism: Neutropenia
  • Management: Antibiotics, supportive care
  • Prevention: Infection prevention, early treatment

Early (Weeks-Months)

1. Remission (60-80%)

  • Mechanism: Chemotherapy works
  • Management: Continue treatment
  • Prevention: Appropriate treatment

2. Relapse (20-40%)

  • Mechanism: Disease returns
  • Management: Re-treat, may need transplant
  • Prevention: Appropriate treatment, monitoring

Late (Months-Years)

1. Cure (30-50%)

  • Mechanism: Disease cured
  • Management: Usually no long-term treatment needed
  • Prevention: Appropriate treatment

2. Relapse or Death (50-70%)

  • Mechanism: Disease not cured
  • Management: Ongoing management, may need transplant
  • Prevention: Appropriate treatment

9. Prognosis & Outcomes

Natural History (Without Treatment)

Untreated Acute Leukaemia:

  • High mortality: 90-100% mortality within months
  • Poor outcomes: If not treated

Outcomes with Treatment

VariableOutcomeNotes
Remission60-80%Most achieve remission
Cure30-50%Varies by type, age, genetics
Mortality20-30%Lower with treatment
Relapse20-40%May relapse

Factors Affecting Outcomes:

Good Prognosis:

  • Young age: Better outcomes
  • Good genetics: Better outcomes
  • Early treatment: Better outcomes
  • Good response: Better outcomes

Poor Prognosis:

  • Older age: Worse outcomes
  • Poor genetics: Worse outcomes
  • Delayed treatment: Worse outcomes
  • Poor response: Worse outcomes

Prognostic Factors

FactorImpact on PrognosisEvidence Level
AgeYounger = betterHigh
GeneticsGood genetics = betterHigh
TypeSome types betterHigh
Early treatmentBetter outcomesModerate

10. Evidence & Guidelines

Key Guidelines

1. NICE Guidelines (2016) — Leukaemia: diagnosis and management. National Institute for Health and Care Excellence

Key Recommendations:

  • Urgent diagnosis
  • Urgent chemotherapy
  • Evidence Level: 1A

Landmark Trials

Multiple studies on chemotherapy regimens, outcomes.

Evidence Strength

InterventionLevelKey EvidenceClinical Recommendation
Urgent chemotherapy1AMultiple studiesEssential
Supportive care1AMultiple studiesEssential

11. Patient/Layperson Explanation

What is Acute Leukaemia?

Acute leukaemia is a cancer of the blood and bone marrow where immature blood cells multiply rapidly and crowd out normal blood cells. Think of your bone marrow as a factory that makes blood cells—in acute leukaemia, the factory starts making too many immature, non-functional cells that can't do their job, while normal blood cells can't be made properly.

In simple terms: Your bone marrow is making too many bad blood cells and not enough good ones. This causes anemia (not enough red cells), infection (not enough normal white cells), and bleeding (not enough platelets). This is serious and needs urgent treatment.

Why does it matter?

Acute leukaemia is a life-threatening condition that requires urgent treatment. Early recognition and prompt chemotherapy are essential. The good news? With proper treatment, many people achieve remission, and some are cured.

Think of it like this: It's like your blood cell factory making too many bad cells—it needs urgent treatment to stop this and start making good cells again.

How is it treated?

1. Diagnosis:

  • Blood tests: You'll have blood tests that show abnormal cells
  • Bone marrow test: You'll have a test of your bone marrow to confirm and see what type
  • Why: To confirm the diagnosis and plan treatment

2. Treat Complications (Urgent):

  • Infection: If you have a fever or infection, you'll get antibiotics urgently
  • Bleeding: If you're bleeding, you'll get platelets to help your blood clot
  • Anemia: If you're very anemic, you'll get a blood transfusion
  • Why: To support your body while the leukaemia is treated

3. Chemotherapy (Urgent):

  • What: You'll get strong medicines (chemotherapy) to kill the leukaemia cells
  • When: Usually starts within days of diagnosis
  • Why: To kill the leukaemia cells and allow your bone marrow to make normal cells again
  • Duration: Usually several months of treatment

4. Supportive Care:

  • Infection prevention: You'll get medicines and precautions to prevent infection
  • Blood products: You'll get blood products (platelets, red cells) as needed
  • Monitoring: Close monitoring for complications

The goal: Kill the leukaemia cells, allow your bone marrow to make normal cells again, and achieve remission (disease under control) or cure.

What to expect

Recovery:

  • Treatment: Usually starts within days
  • Hospital stay: Usually weeks to months (for chemotherapy)
  • Remission: Most people achieve remission (disease under control) within weeks to months
  • Cure: Some people are cured (30-50%), but this varies

After Treatment:

  • Monitoring: Regular monitoring to check if the disease stays in remission
  • Relapse: Some people may have a relapse (disease returns), which can be treated
  • Long-term: Ongoing management, may need further treatment

Recovery Time:

  • Remission: Usually within weeks to months
  • Long-term: Ongoing management

When to seek help

Call 999 (or your emergency number) immediately if:

  • You have a fever and feel very unwell
  • You're bleeding heavily
  • You feel very unwell
  • You have symptoms that concern you

See your doctor if:

  • You have unexplained fatigue, bruising, or infections
  • You have symptoms that concern you
  • You have a known diagnosis of leukaemia and develop new symptoms

Remember: If you have unexplained fatigue, bruising, or infections, especially if you have a fever, see your doctor. Acute leukaemia is serious, but with prompt treatment, many people achieve remission. Don't delay—if you're worried, seek help immediately.


12. References

Primary Guidelines

  1. National Institute for Health and Care Excellence. Leukaemia: diagnosis and management. NICE guideline [NG47]. 2016.

Key Trials

  1. Multiple studies on chemotherapy regimens, outcomes.

Further Resources

  • NICE Guidelines: National Institute for Health and Care Excellence

Last Reviewed: 2025-12-25 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.

Last updated: 2025-12-25

At a Glance

EvidenceHigh
Last Updated2025-12-25
Emergency Protocol

Red Flags

  • Signs of severe infection (fever, sepsis)
  • Signs of severe bleeding
  • Signs of severe anemia
  • Signs of hyperleukocytosis (respiratory distress, neurological symptoms)
  • Signs of tumor lysis syndrome

Clinical Pearls

  • **"Think of it with pancytopenia"** — If a patient has pancytopenia (low red cells, white cells, platelets) with blasts in the blood, think acute leukaemia. Don't miss this.
  • **"Bone marrow biopsy is essential"** — Blood tests may show blasts, but bone marrow biopsy is essential to confirm, classify the type, and guide treatment. Don't skip this.
  • **"Time matters"** — Acute leukaemia is a medical emergency. Once diagnosed, treatment should start urgently (usually within days). Delayed treatment increases mortality.
  • **Red Flags — Immediate Escalation Required:**
  • - **Signs of severe infection (fever, sepsis)** — Medical emergency, needs urgent antibiotics

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines